Portfolio Thuja Capital Healthcare Fund II

Company: MILabs - Visit website
Fund: Thuja Capital Healthcare Fund II
Year: 2016
Status: Active

MILabs is a company based in Utrecht, that develops and sells state of the art molecular imaging devices, for preclinical use. In addition, MILabs is developing a clinical SPECT scanner that will have unprecedented imaging capabilities, allowing doctors to well beyond what they can image today.

Company: Indigo Diabetes - Visit website
Fund: Thuja Capital Healthcare Fund II
Year: 2016
Status: Active

Indigo Diabetes is a Belgian startup developing novel glucose sensor technology based on photonics, thus avoiding the need for frequent calibration